Skip to content Skip to footer

Lassa Fever ;Six More Cases And One Death Are Recorded By The NCDC.

Six additional cases of Lassa fever and one fatality have been reported to the Nigerian Center for Disease Control and Prevention (NCDC).

According to the NCDC’s most recent epidemiological report, the positive cases of the disease occurred in Ondo (5) and Bauchi (1), while Ondo was the location of the death.

According to the Nigerian News Agency (NAN), rats are the carriers of Lassa fever, a viral hemorrhagic fever.Although the virus has been known since the 1950s, it wasn’t discovered until 1969, when two missionary nurses died from it in the Nigerian town of Lassa.

The village of Lassa, where it was first recorded, is the source of its name.

It has the potential to kill tens of thousands of people and is primarily found in West Africa.The virus remains in bodily fluids, including sperm, even after recovery.

Consequently, the virus can easily spread, particularly given that rats can breed rapidly and live in human homes.

Consuming or inhaling rat feces is the most common way to get the disease.It can also spread through open wounds and cuts.

The rats frequently come into contact with food because they live in and around human structures.The disease can be spread during the preparation of the rats, which are sometimes eaten by people.

Blood, tissue, secretions, or excretions can be used to contact another person, but not touch.There have been reports of sexual transmission and the possibility of needle sharing spreading the virus.

The use of blood, tissue, secretions, or excrement cannot be used to touch another person.Sexual transmission and the possibility of sharing needles could spread the virus, according to reports.

A new vaccine developed by researchers at the University of Texas Medical Branch to combat the Lassa Virus, a pathogen that causes Lassa fever, has been successful.

Humans and non-humans alike can die from Lassa fever, which has a mortality rate of up to 70% in hospitalized cases.

In West Africa, up to 500,000 people contract the disease annually.Survivors of Lassa fever may also experience serious, long-lasting effects.

Hearing loss or other neurological issues affect as many as one third of those infected.

The study, which was published in Cell Reports on July 19, was titled “A recombinant VSV-vectored vaccine rapidly protects nonhuman primates against heterologous lethal Lassa fever.”

Show CommentsClose Comments

Leave a comment